Description

VIOPHTAN NR 8 is a protein-peptide eye balm. Targeted peptide-based modulator of the visual analyzer. Used as eye drops.

Indications for use:

Iridocyclitis,
Iris dystrophy,
Open-angle glaucoma.

Composition:

1 ml of sterile solution contains: demineralized water 8.5±0.2 mg NaCl; 0.1±0.01 mg CaCI₂ and 10^-8-10^-9 mg protein-peptide complex.

Source of bioregulator isolation: iris of young bulls.

Physiological action:

Restoration and maintenance of the iris and choroid structure,
Antiviral action,
Anti-inflammatory action,
Improves aqueous humor filtration in the anterior chamber angle of the eye in open-angle glaucoma.

Mode of application:

Viophtan is instilled into the eyes, 1-2 drops at a time, 2-4-6 times, depending on the condition.

Different Viophtans are instilled at intervals of at least 10 minutes.

Benefits:

Do not cause allergic reactions;
Do not cause overdoses (no toxic or even dyspeptic dose);
Do not have side effects or contraindications;
Facilitate the restoration of the normal structure and function of pathologically altered tissues and are resistant to a number of physicochemical factors;
Compatible with any pharmacotherapy (including antibiotics, chemotherapy), radiation therapy, and physical therapy, as they are resistant to a number of physicochemical factors;
Compatible with any naturopathic method - phytotherapy, hirudotherapy, and homeopathic remedies;
Can be administered at any stage of the disease and inflammatory process;
If necessary, several Viorgons and Viophtans can be prescribed simultaneously to correct and prevent multiple conditions;
Viorgons and Viophtans are non-addictive (which is important for long-term management of chronic diseases).

Release form: 15ml (~ 300 drops)

Contraindications: None.

Side effects: None.

Addiction: None.

Shelf life: 2 years

This is not a medicine. It is recommended to consult a doctor before using this product.

100percent

Guaranteed authenticity and quality:

100% Original from the Institute of Bioregulation Problems (Russian Federation).

The Institute of Bioregulation Problems is a private research and production company specializing in the development of protein-peptide complexes and bioregulatory agents (MGTBio).

We also conduct research and development, collaborating with various Russian Academy of Sciences institutes and medical organizations.

To date, we have published over 250 scientific papers and received over 10 patents on protein-peptide bioregulator research.

Development and production:

INSTITUTE OF BIOREGULATION PROBLEMS (Produced in Russia)

VIOPHTAN NR 8 - Bioregulator of the Iris